Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Taurine and Reduced Diastolic Blood Pressure

Doses used in studies

g/day: 0.5–6 (median 3.25, IQR 0.5–6) — 1 study
mg/day: 3,000 (median 3,000, IQR 3,000–3,000) — 1 study

Time to effect

Median: 5 days · IQR 5 days–5 days · Range 5 days–5 days — Reported in 1 of 2 studies

Safety in these studies

Overall tolerabilityReported
a daily dose of 3,000 mg appears to offer an optimal balance between clinical efficacy and tolerability
from: Taurine supplementation as a therapeutic strategy for cellular senescence and chronic infl

2 of 2 papersPopulation:

Taurine reduces the risk for metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials.
- 2024-05-16
- Meta-Analysis · n = 1,024
- Nutrition & diabetes 14(1)
- - Chih-Chen Tzang
  - Liang-Yun Chi
  - Long-Huei Lin
  - Ting-Yu Lin
  - Ke-Vin Chang
  - Wei-Ting Wu
  - Levent Özçakar
- PubMed: 38755142
- DOI: 10.1038/s41387-024-00289-z
6 Insights on
- Reduced Diastolic Blood Pressure
- High evidence
taurine supplementation demonstrated statistically significant reductions in ... DBP (WMD = -1.509 mmHg, 95% CI = -2.479 to -0.539, p = 0.002)
Effect
Beneficial
Effect size
Small
Significant
Yes
Dose
0.5 g/day to 6 g/day
Taurine supplementation as a therapeutic strategy for cellular senescence and chronic inflammation in long COVID: a systematic review and meta-analysis.
- 2026-03-10
- Meta-Analysis · n = 308
- BMC infectious diseases 26(1)
- - Kaiming Wang
  - Chen Hsiang Ma
  - Mobin Khoramjoo
  - Janice Y Kung
  - Gavin Y Oudit
- PubMed: 41803812
- DOI: 10.1186/s12879-026-13009-y
16 Insights on
- Reduced Diastolic Blood Pressure
- High evidence
- Clinical
Supplementation also improved blood pressure and exercise capacity
Effect
Beneficial
Effect size
Moderate
Significant
Yes
Dose
3000 mg/day